← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2010Last known activity
Nov 15, 2025
Timeline
1990s
- Jun 1, 1996
Novotech— Founded
Drugs by trial phase (90 distinct, 82 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (26 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Astrocytoma
- Brain Neoplasms
- Breast Cancer Lymphedema
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Small Cell
- Carcinosarcoma
- Cholangiocarcinoma
- Cholestasis
- Colorectal Neoplasms
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Edema
- Endometrial Neoplasms
- Esophageal Neoplasms
- Fatty Liver
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Herpes Zoster
- Kidney Diseases
- Kidney Neoplasms
- Liver Neoplasms
- Lung Neoplasms
- Lymphedema
- Lymphoma
- Lymphoma, B-Cell
- Macular Edema
- Melanoma
- Mesothelioma
- Microsatellite Instability
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Unknown Primary
- Non-alcoholic Fatty Liver Disease
- Osteoarthritis
- Pancreatic Neoplasms
- Premature Birth
- Premature Ejaculation
- Pruritus
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiration Disorders
- Respiratory Tract Diseases
- Retinal Vein Occlusion
- Squamous Cell Carcinoma of Head and Neck
- Thymoma
- Tongue Neoplasms
- Urologic Neoplasms
Recent trials (50)
- NCT07235293CollaboratorPhase 2Nov 15, 2025
- NCT07219771CollaboratorPhase 3Oct 14, 2025
- NCT06961565CollaboratorPhase 1May 30, 2025
- NCT06717100CollaboratorPhase 1Dec 31, 2024
- NCT06429930CollaboratorPhase 1Sep 1, 2024
- NCT06523153CollaboratorPhase 1Aug 28, 2024
- NCT06698861CollaboratorPhase 1Aug 19, 2024
- NCT06392477CollaboratorPhase 1Jul 15, 2024
- NCT06273813OfficialPhase 1Feb 29, 2024
- NCT06183671CollaboratorPhase 1Jan 1, 2024
- NCT06125691CollaboratorPhase 1Dec 31, 2023
- NCT06101173CollaboratorPhase 1Dec 30, 2023
- NCT05957081CollaboratorPhase 1Nov 28, 2023
- NCT06008652CollaboratorPhase 1Nov 26, 2023
- NCT06013150Lead sponsorPhase 1Oct 23, 2023
Details
- Founded
- Sydney, New South Wales, AU Jun 1, 1996
- Last known activity
- Nov 15, 2025